Skip to main content
Premium Trial:

Request an Annual Quote

Large Scale Biology Q1 Revenues Up Slightly

NEW YORK, April 22 - Large Scale Biology reported today a small increase in revenues for the first quarter, along with a slightly narrower net loss and a steep drop in R&D expenses.

 

The company's revenues totaled $0.9 million for the first quarter of 2002, compared to $0.4 million for the first quarter of last year, but were slightly less than the total revenues the company reported for the fourth quarter of 2002.

 

Research and development expenses for the quarter fell to $3.2 million, from $6.2 million for the year-ago quarter. Last June, the company cut 58 employees and slashed salaries, leaving it with a staff of 127.

 

Large Scale Biology has $19.1 million in cash, cash equivalents, and marketable securities at the end of March, compared to $23.1 million for the same period last year.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.